Clinical Trials Browser

Phase 3 × belantamab mafodotin × 30 days × Clear all

NCT06679101 2026-04-22

DREAMM-10

Phase 3 Recruiting

Multiple Myeloma

NCT04162210 2026-03-31

DREAMM-3

Phase 3 Active not recruiting

325 enrolled 10 charts

Multiple Myeloma